Early diagnostics and incidence of diabetic nephropathy depending on type 1 diabetes mellitus duration

Main Article Content

V.A. Maslianko


The objective — to establish the incidence of diabetic nephropathy (DN) depending on duration of type 1 diabetes mellitus (DM), and also the content of cystatin С as a marker of early kidney damage. Materials and methods. Twenty eight patients with type 1 DM were enrolled in prospective study (11 men and 17 women aged 34.8 ± 7.2 years). Clinical and functional examination included the standard evaluation of renal function, and also the study of serum level of cystatin С. Results. In 17 out of 28 patients, the indexes of glomerular filtration rate calculated using the formulas of CKD-ЕРIcreat and CKD-ЕРIcys, indicated the different stages of chronic kidneys disease. Conclusions. Determination of cystatin C level and calculation of glomerular filtration rate using this index allows diagnosing the preclinical stages of kidney dysfunction in patients with type 1 DM in the normal creatinine level in the blood and without decline in glomerular filtration rate calculated using creatinine value. According to a retrospective study, the incidence and severity of DN in patients with type 1 DM increases with disease duration of more than 10 years.

Article Details

How to Cite
Maslianko, V. “Early Diagnostics and Incidence of Diabetic Nephropathy Depending on Type 1 Diabetes Mellitus Duration”. INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine), vol. 13, no. 2, May 2017, pp. 167-70, doi:10.22141/2224-0721.13.2.2017.100607.
Clinical Diabetology


Coresh J, Astor BS, Greene T, Eknoyan G, Levey AS. Prevalence of chronic kidney disease and decreased function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis. 2003 Jan;41(1):1-12. PMID: 12500213. doi: 10.1053/ajkd.2003.50007.

National Kidney Foundation: K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification and stratification. Am J Kidney Dis. 2007;1:1-39. PMID: 11904577.

Bondar IA, Klimontov VV. Early markers of the diabetic nephropathy. Clinical Nephrology. 2010;2:60-65. (in Russian).

Takir M, Unal AD, Kostek O, Bayraktar N, Demirag NG. Cystatin-C and TGF-β levels in patients with diabetic nephropathy. Nefrologia. 2016;36(6):653-9. PMID: 27745866. doi: 10.1016/j.nefro.2016.06.011.

Javanmardi M., Azadi N.A., Amini S., Abdi M. Diagnostic value of cystatin C for diagnosis of early renal damages in type 2 diabetic mellitus patients: The first experience in Iran. J Res Med Sci. 2015;20(6):571-6. PMID: 26600832. doi:  10.4103/1735-1995.165960.

Perkins BA, Nelson RG, Ostrander BE, Blouch KL, Krolewski AS, Myers BD, Warram JH. Detection of renal function decline in patients with diabetes and normal or elevated GFR by serial measurements of serum cystatin C concentration: Results of a 4-year follow-up study. J Am Soc Nephrol. 2005 May;16(5):1404-12. PMID: 15788478. doi: 10.1681/ASN.2004100854.

Wang T, Wang Q, Wang Z, Xiao Z, Liu L, Lunqin Liu. Diagnostic value of the combined measurement of serum Hcy, serum Cys C, and urinary microalbumin in type 2 diabetes mellitus with early complicating diabetic nephropathy. ISRN Endocrinol 2013;2013:407452. doi: 10.1155/2013/407452.

López Gómez JM, Sacristán Enciso B, Micó M, Arias Meneses F, de Sande Medel F, Alejo S. Serum cystatin C and microalbuminuria in the detection of vascular and renal damage in early stages. Nefrologia. 2011;31:560-6. PMID: 21959722. doi: 10.3265/Nefrologia.pre2011.Jul.10834.

Xia LH, Bing XG, An XT. Serum cystatin C assay for the detection of early renal impairment in diabetic patients. J Clin Lab Anal. 2004;18(1):31-5. PMID: 14730555. doi: 10.1002/jcla.20005.

Perlemoine C, Beauvieux MC, Rigalleau V, Baillet L, Barthes N, Derache P, Gin H. Interest of cystatin C in screening diabetic patients for early impairment of renal function. Metabolism. 2003;52(10):1258-64. PMID:14564676.